Vital Chemtech Ltd

Vital Chemtech has experienced significant sales growth from 57.61 Cr in Mar'22 to 133.90 Cr in Mar'25, despite profitability challenges and fluctuating cash flows, including a loss in Mar'24. Total assets increased from 81.25 Cr to 181.64 Cr during the same period, indicating overall growth despite rising raw material costs.

As of 04-Nov, Vital Chemtech Ltd is seeing a price increase to 65.50, up 1.87%, and has outperformed its sector by 3.59%. The stock shows strong upward momentum with significant trading volume and a 13.03% gain over the past week, contrasting with the declining Sensex.

As of 31-Oct, Vital Chemtech Ltd's stock price is at 61.25, up 4.7% today but down 18.01% year-to-date. Despite recent gains, investor participation has sharply declined, raising concerns about sustained interest in the stock.

As of 27-Oct, Vital Chemtech Ltd's stock price is at 55.20, down 4.33%, and has significantly underperformed its sector and the Sensex over various periods. The stock is trading below all moving averages, with declining investor participation and no positive catalysts for recovery.

As of 08-Oct, Vital Chemtech Ltd's stock price is at 61.95, unchanged, but has outperformed its sector today. Despite recent gains, the stock is down 17.07% year-to-date, indicating longer-term struggles compared to the broader market.

As of 29-Sep, Vital Chemtech Ltd's stock price is at 58.40, up 2.55% today, but down 21.82% year-to-date. Despite recent short-term gains compared to the Sensex, declining delivery volume raises concerns about future investor participation.

As of September 25, 2025, Vital Chemtech's valuation has shifted from very expensive to attractive, indicating it is currently undervalued with a competitive PE ratio of 29.46 compared to peers like Solar Industries and Gujarat Fluoroch, despite a challenging year with a YTD return of -23.76%.

As of 24-Sep, Vital Chemtech Ltd is priced at 55.00, showing a slight increase but a year-to-date decline of 26.37%. The stock is underperforming compared to the Sensex and has seen a significant drop in investor participation, indicating waning interest.

As of September 23, 2025, Vital Chemtech is considered very expensive and overvalued with a PE ratio of 28.35, despite being lower than some peers, and has underperformed the Sensex with a year-to-date return of -26.57%.

As of 23-Sep, Vital Chemtech Ltd's stock price is at 54.85, down 4.53%, and has underperformed its sector and the benchmark Sensex significantly. The stock has declined 26.57% year-to-date, with a notable drop in investor participation and consistent underperformance compared to market averages.

As of September 22, 2025, Vital Chemtech is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 28.45 and a year-to-date stock decline of 23.09%, although it is less overvalued compared to peers like Solar Industries and Gujarat Fluoroch.

As of 22-Sep, Vital Chemtech Ltd's stock price is at 57.45, up 1.68% today but down 6.74% over the past week and 23.09% year-to-date, underperforming the Sensex which is up 6.59% this year. The stock is trading above its 50-day moving average but below other key averages, with reduced investor participation indicated by a 27.08% drop in delivery volume.

As of 19-Sep, Vital Chemtech Ltd's stock price is at 56.50, down 1.74%, and has significantly underperformed its sector and the benchmark Sensex. The stock is in a bearish trend, trading below all major moving averages, with a year-to-date decline of 24.36% and a 25.85% drop over the past year.

As of September 18, 2025, Vital Chemtech is considered very expensive with a PE ratio of 29.62, overvalued compared to peers like Solar Industries and Godrej Industries, and has underperformed the Sensex with a year-to-date return of -23.03%.

As of 18-Sep, Vital Chemtech Ltd's stock price is at 57.50, down 3.36%, and has significantly underperformed its sector and the Sensex. The stock has seen a drastic decline in delivery volume and remains below several key moving averages, indicating weak investor interest and liquidity issues.

As of September 17, 2025, Vital Chemtech is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 30.78, an EV to EBITDA of 20.24, and a PEG ratio of 2.03, while its stock has underperformed year-to-date with a 20.35% decline compared to the Sensex's 7.13% gain.

As of 17-Sep, Vital Chemtech Ltd's stock price is at 59.50, down 0.83%, with recent positive momentum but underperformance compared to the sector and broader market. Despite short-term gains, the stock has significantly lagged year-to-date and over the past year.

As of 16-Sep, Vital Chemtech Ltd's stock price is at 60.00, down 2.6% today, but has gained 9.09% over the past week and 7.82% over the past month. Despite recent short-term gains, the stock has significant year-to-date losses of 19.68% and underperforms compared to the broader market.

As of 11-September, Vital Chemtech Ltd's stock price is at 58.90, up 1.99% today, with significant short-term gains despite a year-to-date decline of 21.15%. The stock's recent performance outpaces its sector, but it still lags behind the broader market benchmark, indicating potential short-term fluctuations rather than a long-term recovery.